News › Clinical Practice, Industry News, Patient Care

Clinical Study Demonstrates Improvement in Injection Recovery with Topical Use of Alastin’s INhance

June 11, 2020

Alastin Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically tested, physician-dispensed skin care products, has announced the publication of a clinical study highlighting its most recent product, INhance post-injection serum with TriHex Technology. The Journal of Drugs in Dermatology (JDD)—the peer-reviewed publication authored by Alan D. Widgerow, MBBCh, MMed (Plast), FCS, Carolyn Jacob, MD, and Melanie D. Palm, MD, MBA—reviews the science behind the product and demonstrates the clinical utility of combining a topical adjunct with injectable procedures.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available